Herpes simplex virus type 1 (HSV-1)-infected human skin fibroblasts were used as target cells in a 51Cr release assay, using peripheral blood mononuclear cells from HSV-seropositive and -seronegative donors as effector cells. Cytotoxicity was exerted by ordinarily prepared lymphoid cells but could be reduced by extensive washing of the effector cells. The antibody dependence of the system was shown by the recovery of activity through addition of positive serum or medium used for the early washes of effector cells. Three donors found to be seronegative in the usual serological tests were shown to be seropositive in this test. It is proposed that the assay can be used as a very sensitive serological test.
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Protection and recovery from viral infections may, among other things, depend on a variety of immunological mechanisms. Antibodies, complement, and different cell types may work alone or together, presumably in a complex manner.
Several in vitro methods measuring parts of the immune response have been developed. In relation to infections caused by herpes simplex virus (HSV) type 1 or 2, measurements of the cell-mediated part of the immune response have been proposed in several types of assays.
One is an effector cell-dependent test system, measuring the killing of HSV-1-infected target cells. This type of system has been used in experiments reported by several investigators (6, 10, 13) Blood donors. Twelve healthy adults, 10 males and 2 females, matched for age, were used as blood donors. Six of the donors were HSV seropositive, and six were HSV seronegative.
Lymphocytes (normally prepared). Lymphocytes were prepared from heparinized peripheral venous blood by Ficoll-Isopaque flotation and then washed twice in TC-199 with 5% FCS. For the first wash the medium contained 15 IU of preservative-free heparin per ml. After washing, the cells were resuspended, counted, and diluted in TC-199 with 5% FCS.
Extensively washed lymphocytes. Instead of two washings, these lymphocytes were washed seven times before use in the cytotoxic assay.
Wash medium. In some of the assays, medium from the second and third washes of lymphocytes was harvested after sedimentation of the lymphoid cells. The medium was used as diluent in the cytotoxic assays instead of fresh TC-199 with 5% FCS. It was used undiluted or in a 1:10 dilution in TC-199-5% FCS. The wash medium was used in different preparations: (i) untreated as described; (ii) further centrifuged at 2,000 rpm for 15 min; or (iii) centrifuged and heat inactivated at 560C for 0.5 h. Unless otherwise stated, preparation (i) was used.
Human sera. All sera were complement inactivated at 56°C for 0.5 h. Cytotoxic assay. A 1-ml portion of lymphocytes in a concentration of 10" per ml was placed in conical plastic tubes (Nunc plastic, 11 by 70 mm), and 60 ,ul of undiluted serum or serum dilutions was added. In tubes in which the wash medium was to be used as diluent, the cells were spun down (1,000 rmp for 10 min), and the supernatant was replaced by the wash medium.
Fibroblasts to be used as target cells were labeled with 51Cr by standard methods and added in 0.1-ml volumes from a cell suspension containing 105 cells per ml (infected or uninfected).
Maximum and spontaneous 5tCr release was determined from tubes containing medium without lymphocytes.
The test tubes were capped and incubated at 37°C for 16 to 18 h. The tubes were then thoroughly agitated and centrifuged at 1,000 rpm for 10 min. 51Cr release was determined by withdrawing 0.7 ml of the supernatant from each tube, and this sample was counted in a gamma counter.
Test tubes with infected target cells were run in duplicate, whereas tubes containing control target cells were usually run single.
Specific 51Cr was calculated by subtracting the percentage of 51Cr release of the control target cells from the mean release of the infected cells according to the formula {[(A -B) x 1001/(C -B)} = percentage of release, where A is the release from the target cells plus lymphocytes, B is spontaneous release, and C is the maximum release.
Antibody pretreatment of target cells. Labeled target cells were incubated with anti-HSV-1-seropositive, heat-inactivated serum or FCS at 37°C for 0.5 to 1 h, after which they were washed five times in TC-199 with 5% FCS.
RESULTS
Initial experiments were performed to determine possible differences in the spontaneous 51Cr release from target cells using different human sera or FCS added to the medium. As no significant differences were found in these experiments, medium with 5% FCS was used as standard for measurements of spontaneous release in the experiments described below.
Effect of extensive washing of lymphocytes. Lymphoid cells from HSV-seropositive and -seronegative donors were used as effector cells in tests without added human serum, and specific killing was calculated (Table 1) . "Normally" washed lymphocytes from seropositives were clearly cytotoxic, exhibiting a specific killing of 37.1 to 3.9% (mean, 22.5%), and the cytotoxic potential was highest in donors with the highest serotiters. Lymphocytes normally prepared from seronegatives gave a significantly lower killing, with a mean of only 1.2%. After being extensively washed, however, lymphocytes from seropositive donors almost entirely lost their cytotoxicity (mean, 5.6%), which was not significantly different from that of the seronegatives (2.5%).
HSV-positive serum was added to both normally prepared and extensively washed lymphocytes from negative donors ( say. Antibodies could not be "washed off' in this situation (Table 3 ). The 51Cr release from target cells pretreated with anti-HSV serum was high after five washes, and also in tubes to which FCS had been added during the assay. FCS-pretreated target cells were, however, only effectively lysed when antibody-containing serum was added. The fibroblasts were washed only five times instead of seven, as was the case with the lymphocytes, since we considered the infected cells vulnerable to too many cycles of washing.
Effect of wash medium. Extensively washed lymphocytes were used with (i) wash medium from the second or third wash as diluent, (ii) TC-199 with 60 ,ul of various dilutions of inac- tivated HSV-positive serum, (iii) TC-199-5% FCS, or (iv) TC-199 with 60 ,1u of dilutions of inactivated serum from the seronegative lymphocyte donors. The positive serum used was from the same serum sample in all assays.
The wash medium from HSV-positive donors was as potent in inducing 51Cr release as was the positive serum, although the anti-HSV antibody titers of the wash medium was found to be <1:4 when tested in the complement fixation test (Fig. 1A) . Two positives showed a somewhat lower level of killing than the other donors, both when using dilutions of wash medium and positive serum.
When autologous serum or "early" wash medium was added to extensively washed lymphocytes from seronegatives (Fig. 1B) , three of them developed marked cytotoxicity, whereas the other three were influenced only negligibly.
Sera from three children aged 9 to 18 months who had not had any HSV infections and whose sera were negative by the neutralization test were also tested in this system (data not shown). They proved to be as "negative" as the above-mentioned "true" negatives. In experiments not illustrated, platelets were removed from the wash medium by centrifugation, and the wash medium was complement inactivated by heat (560C for 30 min). These pretreatments had no influence on the effects exerted by wash medium in the assay.
To demonstrate the antibody nature of the active substance, wash medium from seropositives was passed through an anti-immunoglobulin affinity column; the activity disappeared, but it could be eluted from the column. Similarily, the activity could be eluted from a protein A-Sepharose column, thus demonstrating the immunoglobulin G class of the active antibodies in wash medium.
DISCUSSION
In recent years, cytotoxic assays measuring 51Cr release from virus-infected target cells have been applied to a number of viral systems. In human systems, assays have been made using target cells infected with measles (4), mumps (1, 3) , rubella (5, 9), cytomegalovirus (12) , influenza virus (2), and HSV-1 and -2 (6, 10, 13). This type of reaction has often been considered to be an expression of cell-mediated immunity.
Some groups of investigators (7, 8) have studied an antibody-dependent system in which lymphocytes and antibodies act synergistically in killing the infected target cells. In that system, lymphocytes from seronegative donors are just as effective as killer cells as are lymphocytes from seropositive donors.
In our study, we found that when lymphocytes washed two or three times (as is done by most investigators) were used, the results of the cytotoxic assays could not be regarded as an expression of purely cell-mediated immunity. The outcome of the assays is clearly dependent on antibodies against the appropriate antigen, present in supernatants from washed cells, since we found that the percentage of specific 51Cr release was highly dependent on the number of cycles of washing to which the lymphocytes had been exposed and that in wash media from the second and third washes there were still enough antibodies for the reaction to occur. That this activity was, indeed, due to immunoglobulins in the medium was shown by affinity chromatography.
Two groups working on cytotoxic assays, one with HSV (10) and one with mumps virus (1), experienced difficulty in finding negative donors. In our assay, we found three "negatives" who had cytotoxic activity in serum and wash medium, whereas other negatives were truly without activity in serum.
As the antibody-dependent cytotoxic assay (ADCC) is very sensitive (the antibodies can be diluted up to 100,000 times and still contain appreciable activity [7] ), it seems most logical to assume that in serum from "ADCC-positive seronegatives" we were measuring very low levels of antibodies not detectable in the usual serological assays, so the ADCC system is able to segregate seronegatives in two groups.
In the group of positives, although the difference was not statistically significant, there was still a slightly higher level of killing after extensive washing, as compared with the group of negatives. The difference might be explained in several ways: (i) the entire amount of antibodies may not have been washed off; (ii) a slight production of antibodies may have occurred during the incubation period; or (iii) purely cell-mediated immunity, independent of antibodies, was present. The third possibility will be considered in a subsequent paper (manuscript in preparation).
The assay we present here with extensively washed lymphocytes as effector cells and addition of the serum to be tested can be used as a very sensitive serological test. Furthermore, it is possible to use cells from an unknown donor as effector cells if a known positive serum is used as standard.
